Abbott (NYSE: ABT) is making an important play to expand its cardiovascular device portfolio, announcing that it plans to acquire Cardiovascular Systems (Nasdaq: CSII). The two companies’ agreement, announced after market close yesterday, would provide $20 per common share for Cardiovascular Systems stockholders. The total expected equity value of the deal would be roughly $890 […]
Cardiovascular Systems Inc.
Cardiovascular Systems completes minority investment in CarePICS with option to buy
Cardiovascular Systems (NSDQ:CSII) announced that it completed a minority investment and entered into an option agreement to acquire telehealth company CarePICS. CarePICS offers a virtual care platform designed to aid in the treatment of people with peripheral artery disease (PAD), critical limb ischemia (CLI) and lower extremity wounds, according to a news release. The platform […]
Cardiovascular Systems reports mixed results for Q2
Cardiovascular Systems (NSDQ:CSII) posted second-quarter earnings this evening that beat the consensus forecast on Wall Street, but the company’s revenue missed the mark. The St. Paul, Minn.–based vascular and coronary disease tech company reported a net loss of –$56,000, or 0¢ per share, on sales of $64.2 million for the three months ended Dec. 31, 2020 […]
Cardiovascular Systems up on Street-beating Q1 results
Cardiovascular Systems (NSDQ:CSII) posted first-quarter results that beat the consensus on Wall Street. The St. Paul, Minn.-based company reported losses of -$2.1 million, or -5¢ per share, on sales of $60.5 million for the three months ended Sept. 30, for a sales loss of -6.1% compared with Q1 2020. Earnings per share were -5¢ per share, […]
Cardiovascular Systems up after hours on Street-beating Q4
Cardiovascular Systems (NSDQ:CSII) shares ticked up after hours today on fourth-quarter results that came in ahead of the consensus forecast. The St. Paul, Minn.-based company posted losses of -$15.2 million, or -43¢ per share, on sales of $42.5 million for the three months ended June 30, 2020, for a bottom-line slide into the red on a […]
Cardiovascular Systems’ offering nabs $143.7m
Cardiovascular Systems (NSDQ:CSII) announced today that underwriters fully exercised their option in an offering, leading to proceeds of $143.7 million. Last week, the St. Paul, Minn.-based company commenced an underwritten public offering of common stock shares worth $125 million. The offering included a 30-day option to purchase up to an additional 15% of the shares being […]
Cardiovascular Systems announces $125m public offering
Cardiovascular Systems (NSDQ:CSII) announced that it commenced an underwritten public offering of common stock shares worth $125 million. In connection with the offering, Cardiovascular Systems (CSI) expects to grant underwriters a 30-day option to purchase up to an additional 15% of the shares being offered as well. All shares will be sold by CSI, according to […]
Cardiovascular Systems sinks on missed Q1 revenues
Cardiovascular Systems (NSDQ:CSII) shares dropped today on COVID-19-affected first-quarter results that missed the consensus forecast. The St. Paul, Minn.-based company posted losses of -$2.9 million, or -8¢ per share, on sales of $61.2 million for the three months ended March 31, 2020, sliding into the red from profits of $672,000 year-over-year on a sales decline of […]
Cardiovascular Systems sinks on fiscal Q1 earnings miss
Cardiovascular Systems (NSDQ:CSII) shares sank today after the medical device company missed the consensus earnings forecast for its fiscal first quarter.* Th St. Paul, Minn.-based company doubled its losses to -$5.8 million, or -17¢ per share, on sales growth of 14.6% to $64.5 million for the three months ended Sept. 30, compared with fiscal Q1 2019. […]
Cardiovascular Systems wins FDA approval for ViperWire Advance atherectomy guidewire
Cardiovascular Systems (NSDQ:CSII) said today that it won pre-market approval from the FDA for a new ViperWire Advance coronary guidewire for orbital atherectomies using its Diamondback 360 device. The new guidewire features a floppy, shapeable tip designed to navigate complex anatomies and reduce wire bias, the St. Paul, Minn.-based company said. “We remain committed to expanding […]
Study shows few amputations following treatment with Cardiovascular Systems’ PAD system
A study of peripheral vascular interventions in patients with peripheral artery disease (PAD) has demonstrated “high freedom” from major amputation at three years, according to study sponsor Cardiovascular Systems. The Liberty 360° study enrolled more than 1,200 patients at 51 sites across the U.S. It followed patients across the spectrum of symptomatic PAD, and included […]
